COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
Study Information
Study Attribute Value
CEBS Accession Number: 002-02563-0001-0000-9
Chemical Name: N-Nitrosomorpholine
CASRN: 59-89-2
NTP Study Type: Genetic Toxicology - Mammalian Cell Cytogenetics
NTP Study ID: 579986_SCE
Study Result: Positive

Study Result: Positive
Activation Trial Trial Call
No Activation  Test Failure 
No Activation  Negative 
Induced Rat Liver S9  1_S9  Questionable 
Induced Rat Liver S9  2_S9  Positive 

Trial #: 1    Activation: No Activation    Date: 06/30/1987    Trial Call: Test Failure   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Negative (Not Specified)
0         
50 1046 483 0.462 9.66 25.8 0.000
Test Chemical N-Nitrosomorpholine
500.3       
50 1032 425 0.412 8.50 25.8 -10.815
1670         
50 1039 488 0.470 9.76 25.8 1.716
5000         
50 1037 542 0.523 10.84 25.8 13.189
Positive Control Mitomycin-C
 0.001     
50 1037 538 0.519 10.76 25.8 12.354
Mitomycin-C
 0.01      
5 105 193 1.838 38.60 25.8 298.064
Trend: 2.521        
Probability: 0.006        

Trial #: 2    Activation: No Activation    Date: 09/06/1988    Trial Call: Negative   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Negative (Not Specified)
0         
50 1049 411 0.392 8.22 25.6 0.000
Test Chemical N-Nitrosomorpholine
500         
50 1047 362 0.346 7.24 25.6 -11.754
1670         
50 1048 421 0.402 8.42 25.6 2.531
5000         
50 1047 438 0.418 8.76 30.8 6.773
Positive Control Mitomycin-C
 0.001     
50 1047 688 0.657 13.76 25.6 67.716
Mitomycin-C
 0.01      
5 104 258 2.481 51.60 25.6 533.170
Trend: 1.577        
Probability: 0.057        

Trial #: 1_S9    Activation: Induced Rat Liver S9    Date: 06/30/1987    Trial Call: Questionable   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Negative (Not Specified)
0         
50 1036 497 0.480 9.94 25.8 0.000
Test Chemical N-Nitrosomorpholine
500.3       
50 1047 564 0.539 11.28 25.8 12.289
1670         
50 1040 554 0.533 11.08 25.8 11.040
5000         
50 1045 596 0.570 11.92 25.8 18.887
Positive Control Cyclophosphamide
 0.4       
50 1041 690 0.663 13.80 25.8 38.166
Cyclophosphamide
2         
5 106 210 1.981 42.00 25.8 312.968
Trend: 2.620        
Probability: 0.004        

Trial #: 2_S9    Activation: Induced Rat Liver S9    Date: 07/22/1987    Trial Call: Positive   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Negative (Not Specified)
0         
25 525 223 0.425 8.92 25.5 0.000
Test Chemical N-Nitrosomorpholine
2500         
25 526 327 0.622 13.08 25.5 46.358
3750         
25 524 347 0.662 13.88 25.5 55.902
5000         
25 522 307 0.588 12.28 25.5 38.459
Positive Control Cyclophosphamide
 0.4       
25 514 332 0.646 13.28 25.5 52.065
Cyclophosphamide
2         
5 105 149 1.419 29.80 25.5 234.081
Trend: 3.720        
Probability: 0.000